OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9480	Companies
185562	Keywords
117963	Articles
99396	Press releases

Home
Companies
OXURION

BRIEF

published on 07/14/2025 at 18:05, 4 months 22 days ago

Oxurion annonce les notifications de transparence d'Atlas

Biopharmaceutique Notification Aux Actionnaires Oxurion NV Opportunités Spéciales Atlas Législation Sur La Transparence
PRESS RELEASE

published on 07/14/2025 at 18:00, 4 months 22 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC, in accordance with Belgian Transparency legislation

Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/14/2025 at 18:00, 4 months 22 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV heeft transparantiekennisgevingen ontvangen volgens de Belgische wetgeving betreffende belangrijke deelnemingen. Atlas Special Opportunities II LLC heeft aanzienlijke aandelen in Oxurion verworven en verkocht. Raadpleeg www.oxurion.com voor meer informatie

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Belgische Wetgeving Atlas Special Opportunities II LLC
BRIEF

published on 07/10/2025 at 17:50, 4 months 26 days ago

Oxurion Clears Regulatory Hurdle in Axiodis Acquisition

Acquisition Regulatory Approval Oxurion Axiodis FDI Procedure
BRIEF

published on 07/10/2025 at 17:50, 4 months 26 days ago

Oxurion franchit l'obstacle réglementaire lors de l'acquisition d'Axiodis

Acquisition Approbation Réglementaire Oxurion Axiodis Procédure D'IDE
PRESS RELEASE

published on 07/10/2025 at 17:45, 4 months 26 days ago

Oxurion kondigt het vervullen van de tweede opschortende voorwaarde aan in de overname van Axiodis
Oxurion NV erfüllt zweite aufschiebende Bedingung für die Übernahme von Axiodis CRO. Regulierung der FDI-Prozedur abgeschlossen. Finanzierung und Abschluss innerhalb von 30 Tagen geplant

Übernahme Finanzierung Oxurion NV FDI-Prozedur Klinische Forschung
PRESS RELEASE

published on 07/10/2025 at 17:45, 4 months 26 days ago

Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis
Oxurion NV fulfills acquisition condition of Axiodis CRO with approval from French Ministry, finalizes financing for transaction closure within 30 days

Acquisition Financing French Ministry Oxurion NV Axiodis CRO
PRESS RELEASE

published on 07/10/2025 at 17:45, 4 months 26 days ago

Oxurion annonce la levée de la seconde condition suspensive dans l'acquisition d'Axiodis
Oxurion finalise l'acquisition d'Axiodis CRO en levant la condition suspensive réglementaire du contrôle des investissements étrangers en France

Acquisition Oxurion Axiodis CRO Condition Suspensive Contrôle Investissements Étrangers
BRIEF

published on 07/04/2025 at 18:05, 5 months 1 day ago

Oxurion Boosts Voting Rights with Recent Capital Increase

Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
BRIEF

published on 07/04/2025 at 18:05, 5 months 1 day ago

Oxurion renforce ses droits de vote grâce à une récente augmentation de capital

Actions Obligations Convertibles Augmentation De Capital Oxurion Opportunités Spéciales Atlas

Accesswire

Published on 12/05/2025 at 23:30, 8 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 48 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 1 hour 53 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 8 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 18 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 1 hour 22 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 26 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 40 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours 11 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 5 hours 22 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 38 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 38 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 38 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 38 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 20 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE